NANO MRNA Co.,Ltd.
4571.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.57B
Close$
Share Statistics
| Market cap | $6.57 Billion |
|---|---|
| Enterprise Value | $3.55 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-12.9 |
| Beta | 0.41 |
| Outstanding Shares | 82,998,022 |
Return
| Return on Equity | -30.90% |
|---|---|
| Return on Assets | -19.57% |
| Return on Invested Capital | -21.98% |
Valuation & Multiples
| P/E Ratio | -5.87 |
|---|---|
| PEG | -14.65 |
| Price to Sales | 39.5 |
| Price to Book Ratio | 2.03 |
| Enterprise Value to Revenue | 17.54 |
| Enterprise Value to EBIT | -3.53 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.34 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About NANO MRNA Co.,Ltd.
23 employees
CEO: Shiro Akinaga NANO MRNA Co., Ltd. specializes in the discovery, advancement, and manufacturing of pharmaceutical products, employing its innovative micellar nanoparticle platform. Its biopharmaceutical pipeline is primarily geared towards addressing o...